Kentucky residents who have a nonexpandable lung may have malignant mesothelioma. The lungs of people with malignant mesothelioma are unable to expand to the chest wall, which makes it difficult for them to inhale and exhale normally. This inability of the lung to expand properly can be the result of fibrotic changes in the chest cavity and of inflammation. According to researchers who examined patients who were diagnosed with malignant mesothelioma, a nonexpendable lung in cancer patients who can be an accurate indicator of patient mortality.
Kentucky patients who have been diagnosed with Mesothelioma may be interested to learn that survival rates have not improved throughout the last few decades despite the fact that the treatments for the disease are improving. According to a study, patients with mesothelioma have a median survival rate of 15 months, which has barely changed since 1990.
Researchers hope that a test of breath-based biomarkers can help them detect mesothelioma in its early stages. Louisville residents should know that historically, the U.S. has been lagging behind Europe in the use of breath tests to identify cancer. In 2017, a study from Belgium showed the potential benefits of breath tests for asbestos-related conditions like mesothelioma.
A COMMAND Phase 2 trial of maintenance therapy using the drug defactinib has been found unable to increase the survival rate of patients with malignant pleural mesothelioma. This aggressive and incurable cancer has few treatment options to begin with; Louisville residents should know that the primary treatment is chemotherapy using a combination of the drugs pemetrexed and cisplatin.
A Kentucky resident experiencing problems swallowing may have an early sign indicating a cancer diagnosis of mesothelioma. Known as dysphagia, this type of symptom involving swallowing difficulties is not usually associated with asbestos-related illnesses. However, a Spanish medical journal recently published an article expressing the view that a swallowing problem could indicate the beginning stage of mesothelioma. There are two types of mesothelioma: pleural mesothelioma affects the lungs, and peritoneal mesothelioma affects the abdomen.
Mesothelioma, as Louisville residents may know, is an aggressive cancer usually caused by long-term exposure to asbestos. Among mesothelioma patients, there are several factors that can determine how long they have to live, and Chinese researchers have recently pointed to systemic inflammation as one of those factors. Their results were published in Cancer Management and Research.
Louisville residents should know that mesothelioma is a rare and aggressive form of cancer often found in those who have been exposed to asbestos over a long period of time. In May of 2019, the Food and Drug Administration approved of the first new treatment for mesothelioma in 15 years.
While many Louisville residents may think only of longtime workers in the asbestos industry when they consider the rare cancer called mesothelioma, one recent verdict points to a far more common risk. Johnson & Johnson, the large pharmaceutical and personal-care products corporation, was ordered to pay $25 million to one woman who sued the company after developing mesothelioma. She said that the malignancy was caused by her daily use of talc-based products produced by the company, particularly J&J Baby Powder and Shower to Shower.
Mesothelioma specialists have conducted a study that may be of interest to those in Louisville who know someone with this cancer. Results of the study have been published in the Annals of Surgical Oncology revealing that many mesothelioma patients 80 years and older are dying without receiving any cancer-related treatments. These treatments could have increased the median survival rate, which came to only 4.1 months.
The European Society for Radiotherapy and Oncology held its annual ESTRO 38 conference, during which a study was presented that may intrigue mesothelioma patients in Louisville. The study found that radiotherapy, which has been used to control the symptoms of mesothelioma, may actually do much more that is positive for patients.